In this episode investor Leanne Lee discusses her unique investment philosophy as applied to BioNTech SE, a German medi-tech company focused on developing and manufacturing active immunotherapies. They've also recently partnered with Pfizer to support the COVID vaccine shortage in the EU. We cover the sales potential of BioNtech style businesses; why the metrics of correlation, volatility and factors that drive markets make sense in establishing an accurate valuation; and what risks might affect the future of the company. We also end on the best resources out there for emerging investment talent.

To see Leanne's idea and many more, plus gain access to a high performing global community, head to www.alphaswap.io